Age and autoimmune bleeding disorder linked to similar cell patterns
An observational study compared 40 patients over 65 and 40 aged 65 or younger with healthy adults, finding overlapping immune-cell patterns.
Limit: Many unadjusted comparisons increased the risk of false-positive cell-pattern findings
Edited by Boris Djordjevic · AgingResearch.News
Researchers compared blood samples from 40 adults over 65 and 40 aged 65 or younger with chronic primary immune thrombocytopenia, an autoimmune bleeding disorder. The groups were 62.5% and 67.5% female, respectively. This prospective observational study used healthy comparison groups of 40 older and 60 younger adults.
Older patients had fewer immature B cells, immune cells that can develop into antibody-producing cells, than younger patients. Both patient groups had more of a particular subset of naïve B cells—cells that have not yet encountered their target—than healthy adults their age. This subset lacked CD21 and CD24, two cell-surface proteins. The authors suggested that aging was associated with B-cell changes similar to those seen in the disorder. Expansion of this subset appeared characteristic of the disease, shared with other autoimmune diseases.
Why it matters
This autoimmune bleeding disorder is more prevalent in older adults. Distinguishing age-related immune changes from disease-related ones may help clarify its biology in later life.
Caveats
This observational study could not establish cause and effect, and its many unadjusted comparisons made false-positive findings more likely. It excluded people given treatment to remove B cells within three years, those taking drugs that affect clotting or platelets, and those given a blood transfusion within 15 days.
The paper
Hospital Universitario La Paz
Frontiers in Immunology, May 12, 2026, Open access